Cancer incidence and type of treatment hospital among children, adolescents, and young adults in Japan, 2016–2018

Cancer in children, adolescents, and young adults (AYAs) although rare, is the leading disease‐specific cause of death in Japan. This study aims to investigate cancer incidence and type of treatment hospital among children and AYAs in Japan. Cancer incidence data (2016–2018) for those aged 0–39 year...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer science 2023-09, Vol.114 (9), p.3770-3782
Hauptverfasser: Nakata, Kayo, Matsuda, Tomohiro, Hori, Megumi, Sugiyama, Hiromi, Tabuchi, Ken, Miyashiro, Isao, Matsumoto, Kimikazu, Yoneda, Akihiro, Takita, Junko, Shimizu, Chikako, Katanoda, Kota
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3782
container_issue 9
container_start_page 3770
container_title Cancer science
container_volume 114
creator Nakata, Kayo
Matsuda, Tomohiro
Hori, Megumi
Sugiyama, Hiromi
Tabuchi, Ken
Miyashiro, Isao
Matsumoto, Kimikazu
Yoneda, Akihiro
Takita, Junko
Shimizu, Chikako
Katanoda, Kota
description Cancer in children, adolescents, and young adults (AYAs) although rare, is the leading disease‐specific cause of death in Japan. This study aims to investigate cancer incidence and type of treatment hospital among children and AYAs in Japan. Cancer incidence data (2016–2018) for those aged 0–39 years were obtained from the Japanese population‐based National Cancer Registry. Cancer types were classified according to the 2017 update of the International Classification of Childhood Cancer (Third Edition), and AYA Site Recode 2020 Revision. Cases were also categorized into three groups: those treated at core hospitals for pediatric cancer treatment (pediatric cancer hospitals [PCHs]), those treated at designated cancer care hospitals, and those treated at nondesignated hospitals. The age‐standardized incidence rate was 166.6 (per million‐person years) for children (age 0–14 years) and 579.0 for AYAs (age 15–39 years) (including all cancers and benign or uncertain‐behavior central nervous system [CNS] tumors). The type of cancer varied with age: hematological malignancies, blastomas, and CNS tumors were common in children under 10 years, malignant bone tumors and soft tissue sarcomas were relatively common in teenagers, and in young adults over 20 years, carcinomas in thyroid, testis, gastrointestinal, female cervix, and breast were common. The proportion of cases treated at PCHs ranged from 20% to 30% for children, 10% or less for AYAs, and differed according to age group and cancer type. Based on this information, the optimal system of cancer care should be discussed. The type of cancer in children, adolescents, and young adults in Japan varies according to age: hematological malignancies, blastomas, and central nervous system tumors were common in children under 10 years, malignant bone tumors and soft tissue sarcomas were relatively common in teenagers, and in young adults over 20 years, carcinomas were common.
doi_str_mv 10.1111/cas.15892
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10475761</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2860223945</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4682-8bd39f8b78c3cca5033bb0dc8536d78415476279b7a67fc856c67f927933536d3</originalsourceid><addsrcrecordid>eNp1kctu1TAQhiNERS-w4AWQJTZUalrfYjurqjriUlSJBbC2HNvpSeXYwU5AZ8c78IY8CXPOKRUg4c2MZj7_-kd_VT0n-JzAu7CmnJNGtfRRdUQYb2uJsXi862XdYkYPq-NS7jBmgrf8SXXIJCdccnxUlZWJ1mc0RDs4Dy0y0aF5M3mUejRnb-bRxxmtU5mG2QRkxhRvkV0PwWUfz5BxKfhigSlnu7-btABg3BLmArLovZkMcBQT8fP7DyjqaXXQm1D8s_t6Un1-8_rT6l198-Ht9erqprZcKFqrzrG2V51UlllrGsxY12FnVcOEk4qThktBZdtJI2QPY2GhtjBhbIuwk-pyrzst3ejd1mM2QU95GE3e6GQG_fcmDmt9m75qgrlspCCg8OpeIacviy-zHge4NQQTfVqKpoo1VDImFKAv_0Hv0pIj3AeUwJSyljdAne4pm1Mp2fcPbgjW2yw1ZKl3WQL74k_7D-Tv8AC42APfhuA3_1fSq6uPe8lf8KaoHQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2860223945</pqid></control><display><type>article</type><title>Cancer incidence and type of treatment hospital among children, adolescents, and young adults in Japan, 2016–2018</title><source>DOAJ Directory of Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Wiley-Blackwell Open Access Titles</source><source>PubMed Central</source><creator>Nakata, Kayo ; Matsuda, Tomohiro ; Hori, Megumi ; Sugiyama, Hiromi ; Tabuchi, Ken ; Miyashiro, Isao ; Matsumoto, Kimikazu ; Yoneda, Akihiro ; Takita, Junko ; Shimizu, Chikako ; Katanoda, Kota</creator><creatorcontrib>Nakata, Kayo ; Matsuda, Tomohiro ; Hori, Megumi ; Sugiyama, Hiromi ; Tabuchi, Ken ; Miyashiro, Isao ; Matsumoto, Kimikazu ; Yoneda, Akihiro ; Takita, Junko ; Shimizu, Chikako ; Katanoda, Kota</creatorcontrib><description>Cancer in children, adolescents, and young adults (AYAs) although rare, is the leading disease‐specific cause of death in Japan. This study aims to investigate cancer incidence and type of treatment hospital among children and AYAs in Japan. Cancer incidence data (2016–2018) for those aged 0–39 years were obtained from the Japanese population‐based National Cancer Registry. Cancer types were classified according to the 2017 update of the International Classification of Childhood Cancer (Third Edition), and AYA Site Recode 2020 Revision. Cases were also categorized into three groups: those treated at core hospitals for pediatric cancer treatment (pediatric cancer hospitals [PCHs]), those treated at designated cancer care hospitals, and those treated at nondesignated hospitals. The age‐standardized incidence rate was 166.6 (per million‐person years) for children (age 0–14 years) and 579.0 for AYAs (age 15–39 years) (including all cancers and benign or uncertain‐behavior central nervous system [CNS] tumors). The type of cancer varied with age: hematological malignancies, blastomas, and CNS tumors were common in children under 10 years, malignant bone tumors and soft tissue sarcomas were relatively common in teenagers, and in young adults over 20 years, carcinomas in thyroid, testis, gastrointestinal, female cervix, and breast were common. The proportion of cases treated at PCHs ranged from 20% to 30% for children, 10% or less for AYAs, and differed according to age group and cancer type. Based on this information, the optimal system of cancer care should be discussed. The type of cancer in children, adolescents, and young adults in Japan varies according to age: hematological malignancies, blastomas, and central nervous system tumors were common in children under 10 years, malignant bone tumors and soft tissue sarcomas were relatively common in teenagers, and in young adults over 20 years, carcinomas were common.</description><identifier>ISSN: 1347-9032</identifier><identifier>EISSN: 1349-7006</identifier><identifier>DOI: 10.1111/cas.15892</identifier><identifier>PMID: 37414740</identifier><language>eng</language><publisher>England: John Wiley &amp; Sons, Inc</publisher><subject>adolescent and young adult oncology ; Adolescents ; Age ; Age groups ; Bone tumors ; cancer registration ; Cancer therapies ; Central nervous system ; Chemotherapy ; childhood cancer ; Children ; Classification ; Codes ; epidemiology ; Hospitals ; incidence ; Leukemia ; Malignancy ; Melanoma ; Morphology ; Nervous system ; Original ; ORIGINAL ARTICLES ; Patients ; Pediatrics ; Teenagers ; Thyroid carcinoma ; Topography ; Tumors ; Young adults</subject><ispartof>Cancer science, 2023-09, Vol.114 (9), p.3770-3782</ispartof><rights>2023 The Authors. published by John Wiley &amp; Sons Australia, Ltd on behalf of Japanese Cancer Association.</rights><rights>2023 The Authors. Cancer Science published by John Wiley &amp; Sons Australia, Ltd on behalf of Japanese Cancer Association.</rights><rights>2023. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4682-8bd39f8b78c3cca5033bb0dc8536d78415476279b7a67fc856c67f927933536d3</citedby><cites>FETCH-LOGICAL-c4682-8bd39f8b78c3cca5033bb0dc8536d78415476279b7a67fc856c67f927933536d3</cites><orcidid>0000-0002-7311-1233 ; 0000-0001-9782-8637 ; 0000-0002-2452-6520 ; 0000-0003-2536-0865 ; 0000-0002-2575-4971 ; 0000-0001-8687-1269 ; 0000-0002-0426-5482</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475761/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475761/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,1416,11560,27922,27923,45572,45573,46050,46474,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37414740$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nakata, Kayo</creatorcontrib><creatorcontrib>Matsuda, Tomohiro</creatorcontrib><creatorcontrib>Hori, Megumi</creatorcontrib><creatorcontrib>Sugiyama, Hiromi</creatorcontrib><creatorcontrib>Tabuchi, Ken</creatorcontrib><creatorcontrib>Miyashiro, Isao</creatorcontrib><creatorcontrib>Matsumoto, Kimikazu</creatorcontrib><creatorcontrib>Yoneda, Akihiro</creatorcontrib><creatorcontrib>Takita, Junko</creatorcontrib><creatorcontrib>Shimizu, Chikako</creatorcontrib><creatorcontrib>Katanoda, Kota</creatorcontrib><title>Cancer incidence and type of treatment hospital among children, adolescents, and young adults in Japan, 2016–2018</title><title>Cancer science</title><addtitle>Cancer Sci</addtitle><description>Cancer in children, adolescents, and young adults (AYAs) although rare, is the leading disease‐specific cause of death in Japan. This study aims to investigate cancer incidence and type of treatment hospital among children and AYAs in Japan. Cancer incidence data (2016–2018) for those aged 0–39 years were obtained from the Japanese population‐based National Cancer Registry. Cancer types were classified according to the 2017 update of the International Classification of Childhood Cancer (Third Edition), and AYA Site Recode 2020 Revision. Cases were also categorized into three groups: those treated at core hospitals for pediatric cancer treatment (pediatric cancer hospitals [PCHs]), those treated at designated cancer care hospitals, and those treated at nondesignated hospitals. The age‐standardized incidence rate was 166.6 (per million‐person years) for children (age 0–14 years) and 579.0 for AYAs (age 15–39 years) (including all cancers and benign or uncertain‐behavior central nervous system [CNS] tumors). The type of cancer varied with age: hematological malignancies, blastomas, and CNS tumors were common in children under 10 years, malignant bone tumors and soft tissue sarcomas were relatively common in teenagers, and in young adults over 20 years, carcinomas in thyroid, testis, gastrointestinal, female cervix, and breast were common. The proportion of cases treated at PCHs ranged from 20% to 30% for children, 10% or less for AYAs, and differed according to age group and cancer type. Based on this information, the optimal system of cancer care should be discussed. The type of cancer in children, adolescents, and young adults in Japan varies according to age: hematological malignancies, blastomas, and central nervous system tumors were common in children under 10 years, malignant bone tumors and soft tissue sarcomas were relatively common in teenagers, and in young adults over 20 years, carcinomas were common.</description><subject>adolescent and young adult oncology</subject><subject>Adolescents</subject><subject>Age</subject><subject>Age groups</subject><subject>Bone tumors</subject><subject>cancer registration</subject><subject>Cancer therapies</subject><subject>Central nervous system</subject><subject>Chemotherapy</subject><subject>childhood cancer</subject><subject>Children</subject><subject>Classification</subject><subject>Codes</subject><subject>epidemiology</subject><subject>Hospitals</subject><subject>incidence</subject><subject>Leukemia</subject><subject>Malignancy</subject><subject>Melanoma</subject><subject>Morphology</subject><subject>Nervous system</subject><subject>Original</subject><subject>ORIGINAL ARTICLES</subject><subject>Patients</subject><subject>Pediatrics</subject><subject>Teenagers</subject><subject>Thyroid carcinoma</subject><subject>Topography</subject><subject>Tumors</subject><subject>Young adults</subject><issn>1347-9032</issn><issn>1349-7006</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kctu1TAQhiNERS-w4AWQJTZUalrfYjurqjriUlSJBbC2HNvpSeXYwU5AZ8c78IY8CXPOKRUg4c2MZj7_-kd_VT0n-JzAu7CmnJNGtfRRdUQYb2uJsXi862XdYkYPq-NS7jBmgrf8SXXIJCdccnxUlZWJ1mc0RDs4Dy0y0aF5M3mUejRnb-bRxxmtU5mG2QRkxhRvkV0PwWUfz5BxKfhigSlnu7-btABg3BLmArLovZkMcBQT8fP7DyjqaXXQm1D8s_t6Un1-8_rT6l198-Ht9erqprZcKFqrzrG2V51UlllrGsxY12FnVcOEk4qThktBZdtJI2QPY2GhtjBhbIuwk-pyrzst3ejd1mM2QU95GE3e6GQG_fcmDmt9m75qgrlspCCg8OpeIacviy-zHge4NQQTfVqKpoo1VDImFKAv_0Hv0pIj3AeUwJSyljdAne4pm1Mp2fcPbgjW2yw1ZKl3WQL74k_7D-Tv8AC42APfhuA3_1fSq6uPe8lf8KaoHQ</recordid><startdate>202309</startdate><enddate>202309</enddate><creator>Nakata, Kayo</creator><creator>Matsuda, Tomohiro</creator><creator>Hori, Megumi</creator><creator>Sugiyama, Hiromi</creator><creator>Tabuchi, Ken</creator><creator>Miyashiro, Isao</creator><creator>Matsumoto, Kimikazu</creator><creator>Yoneda, Akihiro</creator><creator>Takita, Junko</creator><creator>Shimizu, Chikako</creator><creator>Katanoda, Kota</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7311-1233</orcidid><orcidid>https://orcid.org/0000-0001-9782-8637</orcidid><orcidid>https://orcid.org/0000-0002-2452-6520</orcidid><orcidid>https://orcid.org/0000-0003-2536-0865</orcidid><orcidid>https://orcid.org/0000-0002-2575-4971</orcidid><orcidid>https://orcid.org/0000-0001-8687-1269</orcidid><orcidid>https://orcid.org/0000-0002-0426-5482</orcidid></search><sort><creationdate>202309</creationdate><title>Cancer incidence and type of treatment hospital among children, adolescents, and young adults in Japan, 2016–2018</title><author>Nakata, Kayo ; Matsuda, Tomohiro ; Hori, Megumi ; Sugiyama, Hiromi ; Tabuchi, Ken ; Miyashiro, Isao ; Matsumoto, Kimikazu ; Yoneda, Akihiro ; Takita, Junko ; Shimizu, Chikako ; Katanoda, Kota</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4682-8bd39f8b78c3cca5033bb0dc8536d78415476279b7a67fc856c67f927933536d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>adolescent and young adult oncology</topic><topic>Adolescents</topic><topic>Age</topic><topic>Age groups</topic><topic>Bone tumors</topic><topic>cancer registration</topic><topic>Cancer therapies</topic><topic>Central nervous system</topic><topic>Chemotherapy</topic><topic>childhood cancer</topic><topic>Children</topic><topic>Classification</topic><topic>Codes</topic><topic>epidemiology</topic><topic>Hospitals</topic><topic>incidence</topic><topic>Leukemia</topic><topic>Malignancy</topic><topic>Melanoma</topic><topic>Morphology</topic><topic>Nervous system</topic><topic>Original</topic><topic>ORIGINAL ARTICLES</topic><topic>Patients</topic><topic>Pediatrics</topic><topic>Teenagers</topic><topic>Thyroid carcinoma</topic><topic>Topography</topic><topic>Tumors</topic><topic>Young adults</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nakata, Kayo</creatorcontrib><creatorcontrib>Matsuda, Tomohiro</creatorcontrib><creatorcontrib>Hori, Megumi</creatorcontrib><creatorcontrib>Sugiyama, Hiromi</creatorcontrib><creatorcontrib>Tabuchi, Ken</creatorcontrib><creatorcontrib>Miyashiro, Isao</creatorcontrib><creatorcontrib>Matsumoto, Kimikazu</creatorcontrib><creatorcontrib>Yoneda, Akihiro</creatorcontrib><creatorcontrib>Takita, Junko</creatorcontrib><creatorcontrib>Shimizu, Chikako</creatorcontrib><creatorcontrib>Katanoda, Kota</creatorcontrib><collection>Wiley-Blackwell Open Access Titles</collection><collection>Wiley Free Content</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Biological Science Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nakata, Kayo</au><au>Matsuda, Tomohiro</au><au>Hori, Megumi</au><au>Sugiyama, Hiromi</au><au>Tabuchi, Ken</au><au>Miyashiro, Isao</au><au>Matsumoto, Kimikazu</au><au>Yoneda, Akihiro</au><au>Takita, Junko</au><au>Shimizu, Chikako</au><au>Katanoda, Kota</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cancer incidence and type of treatment hospital among children, adolescents, and young adults in Japan, 2016–2018</atitle><jtitle>Cancer science</jtitle><addtitle>Cancer Sci</addtitle><date>2023-09</date><risdate>2023</risdate><volume>114</volume><issue>9</issue><spage>3770</spage><epage>3782</epage><pages>3770-3782</pages><issn>1347-9032</issn><eissn>1349-7006</eissn><abstract>Cancer in children, adolescents, and young adults (AYAs) although rare, is the leading disease‐specific cause of death in Japan. This study aims to investigate cancer incidence and type of treatment hospital among children and AYAs in Japan. Cancer incidence data (2016–2018) for those aged 0–39 years were obtained from the Japanese population‐based National Cancer Registry. Cancer types were classified according to the 2017 update of the International Classification of Childhood Cancer (Third Edition), and AYA Site Recode 2020 Revision. Cases were also categorized into three groups: those treated at core hospitals for pediatric cancer treatment (pediatric cancer hospitals [PCHs]), those treated at designated cancer care hospitals, and those treated at nondesignated hospitals. The age‐standardized incidence rate was 166.6 (per million‐person years) for children (age 0–14 years) and 579.0 for AYAs (age 15–39 years) (including all cancers and benign or uncertain‐behavior central nervous system [CNS] tumors). The type of cancer varied with age: hematological malignancies, blastomas, and CNS tumors were common in children under 10 years, malignant bone tumors and soft tissue sarcomas were relatively common in teenagers, and in young adults over 20 years, carcinomas in thyroid, testis, gastrointestinal, female cervix, and breast were common. The proportion of cases treated at PCHs ranged from 20% to 30% for children, 10% or less for AYAs, and differed according to age group and cancer type. Based on this information, the optimal system of cancer care should be discussed. The type of cancer in children, adolescents, and young adults in Japan varies according to age: hematological malignancies, blastomas, and central nervous system tumors were common in children under 10 years, malignant bone tumors and soft tissue sarcomas were relatively common in teenagers, and in young adults over 20 years, carcinomas were common.</abstract><cop>England</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>37414740</pmid><doi>10.1111/cas.15892</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-7311-1233</orcidid><orcidid>https://orcid.org/0000-0001-9782-8637</orcidid><orcidid>https://orcid.org/0000-0002-2452-6520</orcidid><orcidid>https://orcid.org/0000-0003-2536-0865</orcidid><orcidid>https://orcid.org/0000-0002-2575-4971</orcidid><orcidid>https://orcid.org/0000-0001-8687-1269</orcidid><orcidid>https://orcid.org/0000-0002-0426-5482</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1347-9032
ispartof Cancer science, 2023-09, Vol.114 (9), p.3770-3782
issn 1347-9032
1349-7006
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10475761
source DOAJ Directory of Open Access Journals; Wiley Online Library Journals Frontfile Complete; Wiley-Blackwell Open Access Titles; PubMed Central
subjects adolescent and young adult oncology
Adolescents
Age
Age groups
Bone tumors
cancer registration
Cancer therapies
Central nervous system
Chemotherapy
childhood cancer
Children
Classification
Codes
epidemiology
Hospitals
incidence
Leukemia
Malignancy
Melanoma
Morphology
Nervous system
Original
ORIGINAL ARTICLES
Patients
Pediatrics
Teenagers
Thyroid carcinoma
Topography
Tumors
Young adults
title Cancer incidence and type of treatment hospital among children, adolescents, and young adults in Japan, 2016–2018
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T19%3A51%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cancer%20incidence%20and%20type%20of%20treatment%20hospital%20among%20children,%20adolescents,%20and%20young%20adults%20in%20Japan,%202016%E2%80%932018&rft.jtitle=Cancer%20science&rft.au=Nakata,%20Kayo&rft.date=2023-09&rft.volume=114&rft.issue=9&rft.spage=3770&rft.epage=3782&rft.pages=3770-3782&rft.issn=1347-9032&rft.eissn=1349-7006&rft_id=info:doi/10.1111/cas.15892&rft_dat=%3Cproquest_pubme%3E2860223945%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2860223945&rft_id=info:pmid/37414740&rfr_iscdi=true